Tag: Melanoma
-
New SkylineDx Data Show Merlin CP-GEP Test Improves Melanoma Risk Stratification
Introduction: A new benchmark in melanoma risk assessment Recent analyses from SkylineDx present compelling evidence that the Merlin CP-GEP Test offers superior metastatic-risk stratification for melanoma compared with benchmarks released by a major competitor. In a field where precise risk categorization directly informs surgical decisions and patient outcomes, these findings could influence standard-of-care considerations for…
-
Merlin CP-GEP Test from SkylineDx Outperforms Competitors in Melanoma Risk Stratification
New Evidence Places Merlin CP-GEP Test at the Forefront of Melanoma Risk Stratification In the fast-evolving field of melanoma care, precision risk assessment is critical for guiding surgical and medical decisions. SkylineDx has released new data indicating that its Merlin CP-GEP Test provides superior metastatic-risk stratification for melanoma patients, along with more accurate predictions of…
-
SkylineDx Data Underscores Merlin CP-GEP Test’s Superior Melanoma Risk Stratification
New Findings Highlight Merlin CP-GEP Test Performance Fresh data from SkylineDx indicate that the Merlin CP-GEP test offers superior metastatic-risk stratification for melanoma and more accurate prediction of sentinel lymph node biopsy (SLNB) outcomes than rival benchmarks. In a landscape where accurate risk stratification informs crucial treatment decisions, these results position Merlin CP-GEP as a…
-
Grey Hair Could Signal Lower Skin Cancer Risk: New Study
Grey Hair and Skin Cancer: What the Study Found Grey hair has long been viewed mainly as a sign of aging, but a new study suggests it might also carry information about how the body fights melanoma, the deadliest form of skin cancer. Researchers observed that individuals with grey or white hair tended to show…
-
Grey Hair May Signal Lower Skin Cancer Risk: New Study Suggests Protective Link
Grey Hair and Melanoma Protection: What the Study Suggests Grey hair is commonly viewed as a marker of aging, but a new line of research is exploring a surprising potential benefit: a possible link between grey hair and a reduced risk of melanoma, the deadliest form of skin cancer. Scientists are investigating whether the body’s…
-
Grey Hair Could Signal Lower Skin Cancer Risk, New Study Finds
Grey Hair as a Possible Indicator of Melanoma Protection What if the common sign of aging — grey hair — could also reveal something hopeful about our immune defenses? A recent study highlighted by Women’s Health suggests that grey hair might be more than a cosmetic change; it could be a marker of the body’s…
-
Dormant BRAF Mutations in Healthy Skin Challenge Melanoma Screening Assumptions
New findings reshape how we think about melanoma risk A recent study from researchers at the University of Queensland is prompting scientists and clinicians to rethink a long-held belief about how melanoma develops. The team has identified a genetic mutation in the BRAF gene that can lie dormant in healthy skin for years before potentially…
-
Dormant BRAF Mutation in Healthy Skin Challenges Melanoma Screening Assumptions
New Insights from University of Queensland on Melanoma Causes Melanoma research has long been guided by a central assumption: genetic mutations linked to the cancer typically appear in visible, tanning-prone skin or spots that already show abnormal changes. Groundbreaking work from researchers at the University of Queensland (UQ) is turning that idea on its head.…
-
Study challenges conventional wisdom on a common cause of melanoma
New clues about melanoma risk from an unlikely place Melanoma, the deadliest form of skin cancer, has long been associated with visible sun damage and a specific set of genetic mutations. Among these, changes in the BRAF gene have been a focal point for researchers and clinicians alike. A recent study from the University of…
-
Could COVID Vaccines Help Fight Cancer? What the New Findings Mean
Could the COVID-19 vaccine help in the fight against cancer? Emerging research is stirring new questions about how COVID-19 vaccines, particularly mRNA vaccines, might interact with cancer therapies. A study analyzing more than 1,000 patient records suggests that receiving a COVID-19 mRNA vaccine within 100 days of starting immunotherapy was associated with longer survival for…